US Patent 9347044 Reprogramming T cells and hematopoietic cells
Patent 9347044 was granted and assigned to Cellular Dynamics International on May, 2016 by the United States Patent and Trademark Office.
All edits
Edits on 8 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 5 Dec, 2023
Golden AI
Edits made to:
Article (+470 characters)
Article
Patent abstract
Methods and compositions relating to the production of induced pluripotent stem cells (iPS cells) are disclosed. For example, induced pluripotent stem cells may be generated from CD34+ hematopoietic cells, such as human CD34+ blood progenitor cells, or T cells. Various iPS cell lines are also provided. In certain embodiments, the invention provides novel induced pluripotent stem cells with a genome comprising genetic rearrangement of T cell receptors.
Edits on 29 Sep, 2023
Golden AI
Edits made to:
Infobox (+6 properties)
Infobox
Patent Inventor Names
Amanda Mack0
Deepika Rajesh0
Elizabeth Rondon Dominguez0
Emile Nuwaysir0
Matthew Brown0
Randy Learish0
Edits on 14 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09347044 Reprogramming T cells and hematopoietic cells US Patent 9347044 Reprogramming T cells and hematopoietic cells
Infobox
Patent Number
093470440
Patent Number
93470440
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 3 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
093470440
Date of Patent
May 24, 2016
0Patent Application Number
142589710
Date Filed
April 22, 2014
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 6 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09347044 Reprogramming T cells and hematopoietic cells
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09347044
Date of patent
May 24, 2016
Patent application number
14258971
Date Filed
April 22, 2014
Patent primary examiner
Find more entities like US Patent 9347044 Reprogramming T cells and hematopoietic cells
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
